Nuvo Pharmaceuticals, Anti-Inflammatory Medicine with Less Side Effects, CEO Clip Video

Vancouver, British Columbia--(Newsfile Corp. - June 24, 2016) - President & CEO, John London, Nuvo Pharmaceuticals (TSX: NRI), explains how their company's topical anti-inflammatory drugs are different from oral drugs.

If you cannot view the video above, please visit:
http://www.b-tv.com/nuvo-pharmaceuticals-ceo-clip/

Nuvo Pharmaceuticals is being featured on CBC's Documentary Channel Jun 27-Jul 10, 2016, Monday through Friday, throughout the day and evenings.

Nuvo Pharmaceuticals (TSX: NRI),

Nuvo is a commercial healthcare business with a portfolio of products and pharmaceutical manufacturing capabilities.  Nuvo Pharma has three commercial products that are available in a number of countries, Pennsaid 2%, Pennsaid and the HLT Patch.  Nuvo Pharma is focused on licensing the rights to Pennsaid 2% in those territories that are available, as well as looking for new contract manufacturing opportunities and strategic acquisitions to increase the commercial product portfolio and to expand its manufacturing capacity and capabilities. http://www.nuvopharmaceuticals.com/

About CEO Clips:

CEO Clips is the largest library of publicly traded company CEO videos in the US and Canada.  These 90 second video profiles broadcast on national TV and are distributed online on top financial portals including: Thomson Reuters, BNN.ca, and Stockhouse.com.  They are also disseminated via a video news release to several financial portals including Globe Investor, OTC Markets, TMX Money, and The National Post.

BTV - Business Television/CEO Clip Contact: Trina Schlingmann (604) 664-7401 x 5 trina@b-tv.com